DISCLOSURE:
When you click on links to various merchants on this site and make a purchase, this can result in this site earning a commission at no extra cost to you. Affiliate programs and affiliations include, but are not limited to, the eBay Partner Network, Amazon and Alibris.
Maximov, Philipp Y, and McDaniel, Russell E, and Jordan, V Craig, Ph.D., DSc
USD
187.87
Alibris /Alibris
Basel Springer 2013 2013 ed. Hard cover New. Sewn binding. Cloth over boards. 199 p. Contains: Unspecified, Illustrations, black & white. Milestones in Drug Therapy.
ISBN10: 3034806639, ISBN13: 9783034806633, [publisher: Springer Basel] Hardcover Druck auf Anfrage Neuware - Printed after ordering - Tamoxifen is a pioneering medicine for the treatment and prevention of breast cancer. It is the first drug targeted therapy in cancer to be successful. Tamoxifen targets the tumor estrogen receptor. The therapy is known to have saved the lives of millions of women over the past 40 years.This monograph, written by V. Craig Jordan - known as the 'father of tamoxifen' - and his Tamoxifen Team at the Georgetown University Washington DC, illustrates the journey of this milestone in medicine. It includes a personal interview with V. Craig Jordan about his four decades of discovery in breast cancer research and treatment. V. Craig Jordan was there for the birth of tamoxifen as he is credited for reinventing a 'failed morning after contraceptive' to become the 'gold standard' for the treatment of breast cancer. He contributed to every aspect of tamoxifen application in therapeutics and all aspects of tamoxifen's pharmacology. He discovered the selective estrogen receptor modulators (SERMs) and explored the new biology of estrogen-induced apoptosis. [Einbeck, Germany] [Publication Year: 2013] ...
Maximov, Philipp Y, and McDaniel, Russell E, and Jordan, V Craig, Ph.D., DSc
USD
209.11
ShopSpell via Alibris /Alibris
Basel Springer 2013 2013 ed. Hard cover New. Sewn binding. Cloth over boards. 199 p. Contains: Unspecified, Illustrations, black & white. Milestones in Drug Therapy.
ISBN10: 3034806639, ISBN13: 9783034806633, [publisher: Springer Basel] Hardcover Druck auf Anfrage Neuware - Printed after ordering - Tamoxifen is a pioneering medicine for the treatment and prevention of breast cancer. It is the first drug targeted therapy in cancer to be successful. Tamoxifen targets the tumor estrogen receptor. The therapy is known to have saved the lives of millions of women over the past 40 years.This monograph, written by V. Craig Jordan - known as the 'father of tamoxifen' - and his Tamoxifen Team at the Georgetown University Washington DC, illustrates the journey of this milestone in medicine. It includes a personal interview with V. Craig Jordan about his four decades of discovery in breast cancer research and treatment. V. Craig Jordan was there for the birth of tamoxifen as he is credited for reinventing a 'failed morning after contraceptive' to become the 'gold standard' for the treatment of breast cancer. He contributed to every aspect of tamoxifen application in therapeutics and all aspects of tamoxifen's pharmacology. He discovered the selective estrogen receptor modulators (SERMs) and explored the new biology of estrogen-induced apoptosis. [Einbeck, Germany] [Publication Year: 2013] ...
Maximov, Philipp Y, and McDaniel, Russell E, and Jordan, V Craig, Ph.D., DSc
USD
230.96
Ria Christie Books via Alibris /Alibris
Basel Springer 2013 2013 ed. Hard cover New. Sewn binding. Cloth over boards. 199 p. Contains: Unspecified, Illustrations, black & white. Milestones in Drug Therapy.
ISBN10: 3034806639, ISBN13: 9783034806633, [publisher: Springer Basel] Hardcover Hardcover. Tamoxifen is a pioneering medicine for the treatment and prevention of breast cancer. It is the first drug targeted therapy in cancer to be successful. Tamoxifen targets the tumor estrogen receptor. The therapy is known to have saved the lives of millions of women over the past 40 years.This monograph, written by V. Craig Jordan - known as the father of tamoxifen - and his Tamoxifen Team at the Georgetown University Washington DC, illustrates the journey of this milestone in medicine. It includes a personal interview with V. Craig Jordan about his four decades of discovery in breast cancer research and treatment. V. Craig Jordan was there for the birth of tamoxifen as he is credited for reinventing a failed morning after contraceptive to become the gold standard for the treatment of breast cancer. He contributed to every aspect of tamoxifen application in therapeutics and all aspects of tamoxifens pharmacology. He discovered the selective estrogen receptor modulators (SERMs) and explored the new biology of estrogen-induced apoptosis. Craig Jordan was there for the birth of tamoxifen as he is credited for reinventing a failed morning after contraceptive to become the gold standard for the treatment of breast cancer. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. [Wilmington, DE, U.S.A.] [Publication Year: 2013]
ISBN10: 3034806639, ISBN13: 9783034806633, [publisher: Springer Basel] Hardcover Hardcover. Tamoxifen is a pioneering medicine for the treatment and prevention of breast cancer. It is the first drug targeted therapy in cancer to be successful. Tamoxifen targets the tumor estrogen receptor. The therapy is known to have saved the lives of millions of women over the past 40 years.This monograph, written by V. Craig Jordan - known as the father of tamoxifen - and his Tamoxifen Team at the Georgetown University Washington DC, illustrates the journey of this milestone in medicine. It includes a personal interview with V. Craig Jordan about his four decades of discovery in breast cancer research and treatment. V. Craig Jordan was there for the birth of tamoxifen as he is credited for reinventing a failed morning after contraceptive to become the gold standard for the treatment of breast cancer. He contributed to every aspect of tamoxifen application in therapeutics and all aspects of tamoxifens pharmacology. He discovered the selective estrogen receptor modulators (SERMs) and explored the new biology of estrogen-induced apoptosis. Craig Jordan was there for the birth of tamoxifen as he is credited for reinventing a failed morning after contraceptive to become the gold standard for the treatment of breast cancer. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. [Truganina, VIC, Australia] [Publication Year: 2 ...
ISBN10: 3034806639, ISBN13: 9783034806633, [publisher: Springer Basel] Hardcover Hardcover. Tamoxifen is a pioneering medicine for the treatment and prevention of breast cancer. It is the first drug targeted therapy in cancer to be successful. Tamoxifen targets the tumor estrogen receptor. The therapy is known to have saved the lives of millions of women over the past 40 years.This monograph, written by V. Craig Jordan - known as the father of tamoxifen - and his Tamoxifen Team at the Georgetown University Washington DC, illustrates the journey of this milestone in medicine. It includes a personal interview with V. Craig Jordan about his four decades of discovery in breast cancer research and treatment. V. Craig Jordan was there for the birth of tamoxifen as he is credited for reinventing a failed morning after contraceptive to become the gold standard for the treatment of breast cancer. He contributed to every aspect of tamoxifen application in therapeutics and all aspects of tamoxifens pharmacology. He discovered the selective estrogen receptor modulators (SERMs) and explored the new biology of estrogen-induced apoptosis. Craig Jordan was there for the birth of tamoxifen as he is credited for reinventing a failed morning after contraceptive to become the gold standard for the treatment of breast cancer. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. [Stevenage, United Kingdom] [Publication Year: 2 ...
Maximov, Philipp Y.; McDaniel, Russell E.; Jordan, V. Craig
USD
322.19
Kennys Bookstore /Abebooks
ISBN10: 3034806639, ISBN13: 9783034806633, [publisher: Springer Basel] Hardcover Tamoxifen Series: Milestones in Drug Therapy. Num Pages: 224 pages, biography. BIC Classification: MJCL; MJG; MMG. Category: (P) Professional & Vocational. Dimension: 241 x 161 x 18. Weight in Grams: 478. . 2013. 2013th Edition. Hardcover. . . . . Books ship from the US and Ireland. [Olney, MD, U.S.A.] [Publication Year: 2013]
DISCLOSURE:
When you click on links to various merchants on this site and make a purchase, this can result in this site earning a commission at no extra cost to you. Affiliate programs and affiliations include, but are not limited to, the eBay Partner Network, Amazon and Alibris.
